A Biomarker Study of Secukinumab in Rheumatoid Arthritis (RA) Patients

Clinical trial NCT01426789 · COMPLETED

Trial details

NCT number: NCT01426789
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2011-08-01
Primary completion: 2014-02-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.